Literature DB >> 11785687

Immediate and short-term cellular and biochemical responses to pulmonary single-dose studies of insulin and H-MAP.

L Garcia-Contreras1, D Sarubbi, E Flanders, D O'Toole, J Smart, C Newcomer, A J Hicke.   

Abstract

PURPOSE: It was previously reported that co-administration of H-MAP to the airways of the lungs significantly influenced the absorption, disposition. and effect of insulin in a dose-dependent fashion. Doses of H-MAP (16 mg/kg) and insulin (1.3 U/kg) required to achieve maximum pharmacokinetic and pharmacodynamic responses were determined. The purpose of the present study was to evaluate the effects of insulin and H-MAP spray-instilled (SI) to rats on the physiology of the lung. A short-term, single-dose study of insulin alone and combined with H-MAP was performed.
METHODS: Solutions of either insulin (INS), H-MAP, or insulin plus H-MAP (INMA) were SI to the lungs of rats. Lipopolysaccharide solution (LPS) and sodium dodecyl sulfate solution (SDS) were used as positive controls. and normal saline (SAL) was used as negative control. Animals were sacrificed at various time points and bronchoalveolar lavage (BAL) was conducted. BAL fluid was analyzed for local markers of lung injury, such as total cell numbers, differential cell count, total protein content and enzyme activities of lactate dehydrogenase (LDH), alkaline phosphatase (ALP) and N-acetyl glucosaminidase (NAG).
RESULTS: SI of any solution, including normal saline, seems to have a minor but detectable effect on the normal physiology of the lung. SI of positive control solutions resulted in most markers of immunity and lung injury being significantly elevated, notably enzyme activity and white cell infiltrate. In contrast, SI of INS produced a response similar to that of SAL. SI of INMA resulted in a small transient response characterized by a slight increase in the proportion of neutrophils at 24 h, which decreased with time and was comparable to that of SAL at 72

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11785687     DOI: 10.1023/a:1013314311619

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  25 in total

1.  Inhaled insulin.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1999-02-01       Impact factor: 15.470

Review 2.  Recent advances in pulmonary drug delivery using large, porous inhaled particles.

Authors:  D A Edwards; A Ben-Jebria; R Langer
Journal:  J Appl Physiol (1985)       Date:  1998-08

Review 3.  Pulmonary drug delivery: physiologic and mechanistic aspects.

Authors:  J Yu; Y W Chien
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1997       Impact factor: 4.889

4.  Insulin across respiratory mucosae by aerosol delivery.

Authors:  F W Wigley; J H Londono; S H Wood; J C Shipp; R H Waldman
Journal:  Diabetes       Date:  1971-08       Impact factor: 9.461

5.  Study on pulmonary delivery of salmon calcitonin in rats: effects of protease inhibitors and absorption enhancers.

Authors:  S Kobayashi; S Kondo; K Juni
Journal:  Pharm Res       Date:  1994-09       Impact factor: 4.200

6.  Intratracheal delivery of peptide and protein agents: absorption from solution and dry powder by rat lung.

Authors:  F Komada; S Iwakawa; N Yamamoto; H Sakakibara; K Okumura
Journal:  J Pharm Sci       Date:  1994-06       Impact factor: 3.534

7.  N-acylated alpha-amino acids as novel oral delivery agents for proteins.

Authors:  A Leone-Bay; N Santiago; D Achan; K Chaudhary; F DeMorin; L Falzarano; S Haas; S Kalbag; D Kaplan; H Leipold
Journal:  J Med Chem       Date:  1995-10-13       Impact factor: 7.446

8.  Inhalation delivery systems with compliance and disease management capabilities.

Authors:  I Gonda; J A Schuster; R M Rubsamen; P Lloyd; D Cipolla; S J Farr
Journal:  J Control Release       Date:  1998-04-30       Impact factor: 9.776

9.  Absorption enhancement of intrapulmonary administered insulin by various absorption enhancers and protease inhibitors in rats.

Authors:  A Yamamoto; S Umemori; S Muranishi
Journal:  J Pharm Pharmacol       Date:  1994-01       Impact factor: 3.765

10.  Injury versus inflammatory response in the lungs of rats intratracheally inoculated with bacterial lipopolysaccharide.

Authors:  A Lopez; S Yong
Journal:  Am J Vet Res       Date:  1986-06       Impact factor: 1.156

View more
  4 in total

1.  Liquid chromatographic determination of CPZEN-45, a novel anti-tubercular drug, in biological samples.

Authors:  S N M Hanif; A J Hickey; L Garcia-Contreras
Journal:  J Pharm Biomed Anal       Date:  2013-10-06       Impact factor: 3.935

Review 2.  Scale of health: indices of safety and efficacy in the evolving environment of large biological datasets.

Authors:  Christie M Sayes; Herman Staats; Anthony J Hickey
Journal:  Pharm Res       Date:  2014-06-12       Impact factor: 4.200

3.  Pharmacokinetics of sequential doses of capreomycin powder for inhalation in guinea pigs.

Authors:  L Garcia-Contreras; Pavan Muttil; John K Fallon; Mohan Kabadi; Robert Gerety; Anthony J Hickey
Journal:  Antimicrob Agents Chemother       Date:  2012-02-13       Impact factor: 5.191

4.  Evaluation of novel particles as pulmonary delivery systems for insulin in rats.

Authors:  Lucila Garcia-Contreras; Tülin Morçöl; Steve J D Bell; Anthony J Hickey
Journal:  AAPS PharmSci       Date:  2003
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.